Primary percutaneous coronary intervention (pPCI) is the most effective reperfusion strategy for patients with acute ST-segment elevation myocardial infarction (STEMI). 1 Nonetheless, the success of pPCI for STEMI is currently limited by suboptimal myocardial tissue reperfusion despite achieving epicardial coronary patency, mainly secondary to distal thrombus embolization and microvascular obstruction. Suboptimal coronary reperfusion in patients with STEMI is associated with worse outcomes. 2, 3 Manual thrombus aspiration (TA) during pPCI has been introduced with the intent to reduce thrombus burden, prevent distal embolization and increase microvascular perfusion. However, the clinical benefit of manual TA during pPCI remains uncertain. A single-center randomized trial demonstrated improved myocardial reperfusion and a nearly 50% reduction in one-year mortality among STEMI patients undergoing manual TA compared with pPCI alone, 4, 5 whereas two recent large-scale multicenter randomized trials powered for clinical outcomes [6] [7] [8] [9] and large-scale meta-analysis 10 have consistently shown that routine manual TA during pPCI for STEMI did not reduce all-cause mortality and major adverse cardiovascular events (MACE) during short-and long-term follow-up compared with pPCI alone and might be associated with an increased risk of stroke. Accordingly, current European Society of Cardiology 1 and American College of Cardiology/American Heart Association guidelines 11 do not recommend the routine use of manual TA during pPCI for STEMI. However, the question of whether selected patient subgroups may benefit from manual TA during pPCI remains matter of debate due to the lack of robust randomized evidence.
Total ischemic time (TIT), defined as time from symptom onset to reperfusion therapy, is an important independent predictor of myocardial reperfusion, myocardial infarct size, and long-term clinical outcomes in patients undergoing pPCI for STEMI. [12] [13] [14] [15] There is conflicting evidence with regards to the potential interaction between TIT and the effect of manual TA during pPCI. Recent studies have suggested beneficial effects of manual TA over pPCI alone with respect to myocardial reperfusion 16 and rates of death or MACE 17 among patient with longer times to treatment. Contrariwise, in a recent large-scale meta-regression analysis, TIT did not influence any potential benefits observed with manual TA. 10 We aimed to assess the impact of TIT on the clinical benefits of manual TA in a large cohort of STEMI patients undergoing pPCI in contemporary practice.
Methods

Study design
We conducted a retrospective analysis of patients included in AMIS (Acute Myocardial Infarction in Switzerland) Plus, a large, nationwide, multicenter registry of patients admitted with acute coronary syndrome (ACS) to hospitals in Switzerland. The design of the registry has been described previously. 18 Briefly, AMIS Plus prospectively collects 230 items on baseline characteristics, out-of-hospital and early in-hospital management, reperfusion strategy, immediate drug therapy, hospital course, discharge medication and follow-up of patients presenting with ACS in Switzerland. From 106 hospitals treating ACS in Switzerland, 82 hospitals temporarily or continuously enrolled patients in AMIS Plus. Participating centers provide blinded data for each patient through a web-based database and are strongly encouraged to enroll all consecutive patients fulfilling inclusion criteria to avoid selection bias. Hospital data are provided and completed by the treating physician or a trained study nurse. All data are checked for completeness, plausibility and consistency by the AMIS Plus Data Center at the Epidemiology, Biostatistics and Prevention Institute of the University of Zurich, Switzerland.
Study population
We examined a cohort of STEMI patients included in AMIS Plus who underwent pPCI within 12 hours of symptom onset from January 2008 to December 2014. STEMI was defined by presence of symptoms of ischemia and at least 1-mm (presumed) new persistent ST-segment elevation in ≥2 contiguous limb leads or at least 2-mm in ≥2 contiguous precordial leads, or (presumed) new left bundle branch block. Manual TA was performed at the operator's discretion using one of the approved aspiration devices and was followed by conventional PCI to the culprit lesion. No mechanical aspiration devices were included in this analysis. The choice of antithrombotic therapy was left to the discretion of the treating physician. Epicardial reperfusion was assessed using the Thrombolysis in Myocardial Infarction (TIMI) flow grading system before and after pPCI. TIT was defined as time from symptom onset until pPCI. Patients were divided into two groups based on the use of manual TA before PCI (TA group) or PCI only (PCI-alone group). The TA group included all patients in whom manual TA was attempted. Patients were further stratified into three time groups based on TIT, defined as short (b3 hours), intermediate (between 3 to 6 hours), and long (N6 hours).
Study endpoints
The primary endpoint was all-cause mortality during the hospital period. The secondary endpoint was MACE, a composite of all-cause death, non-fatal myocardial reinfarction, or stroke, during the hospital period. Non-fatal myocardial reinfarction was defined as presence of recurrent symptoms with concomitant suggestive electrocardiogram (ECG) changes and/or at least two-fold increase in cardiac biomarkers above the upper limit of normal. Stroke was defined as the presence of a new focal neurological deficit thought to be of vascular origin, with signs or symptoms lasting more than 24 hours.
Statistical analysis
The results are presented as percentages for categorical variables and analyzed using the chi-square test or the Fisher's exact test as appropriate. Continuous normally distributed variables are expressed as means ± standard deviation (SD) and compared using the two-tailed Student's t-test. Continuous non-normally distributed variables were analyzed using the Mann-Whitney U test and expressed as median and interquartile ranges (IQR). A multivariate logistic regression analysis was performed to account for confounding variables and potential bias between the two treatment groups, including age, gender, diabetes, hypertension, chronic renal failure, multivessel disease, anterior infarction and cardiogenic shock. The results are expressed as odds ratio (OR) and 95% confidence interval (CI). A p-value of b0.05 was considered as statistically significant. SPSS software (version 24.0.0, SPSS Inc., Chicago, Illinois, USA) was used for all statistical analyses.
Ethical considerations
The study protocol complies with the Declaration of Helsinki regarding investigations on humans and was approved the Swiss board for data security and all regional ethics commissions.
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Results
From 1
st January 2008 to 30 th April 2014, 18'177 patients with ACS from 51 Swiss hospitals were prospectively enrolled in the AMIS Plus registry. Among 9'715 patients presenting with STEMI during the study period, 8'529 underwent pPCI and the use of manual TA was documented for 5'538 patients. We further excluded 1'384 patients due to missing data on TIT (n=1'199), peak CK level (n=89) and glycoprotein (GP) IIb/IIIa inhibitors use (n=96). A total of 4'154 patients were included for analysis. Of these, 1'988 (48%) underwent manual TA during pPCI, whereas 2'166 patients (52%) were treated with PCI only. The study population was further divided according to the TIT into three subgroups: short TIT b3 hours (1'644 patients; TA group, 843 patients; PCI-alone group, 801 patients), intermediate TIT between 3 to 6 hours (1'364 patients; TA group, 668 patients; PCI-alone group, 696 patients), and long TIT between N6 hours (1'146 patients; TA group, 477 patients; PCI-alone group, 669 patients) ( Figure 1 ).
Baseline characteristics
The baseline characteristics of the study population are listed in Table I . Overall, patients in the TA group were younger, more likely male, and had lower rates of hypertension and diabetes mellitus compared with patients in the PCI-alone group. Patients undergoing manual TA had shorter median TIT [200 (IQR 136 to 347) vs. 224 minutes (IQR 146 to 442); pb0.001] compared with patients undergoing PCI only. The rates of cardiogenic shock and anterior MI were not statistically different between the two groups. Patients in the TA group were less often on aspirin or a P2Y 12 receptor antagonist prior to admission compared with patients in the PCI-alone group. There were higher rates of GP IIb/IIIa inhibitors use in the TA group than in the PCI-alone group (40.1% vs. 18.9%; pb0.001). Patients undergoing manual TA were less likely to have multivessel coronary artery disease (17.1 vs. 26.9%; pb0.001) and the culprit artery was more frequently located on the left anterior descending artery and right coronary artery compared with patients undergoing pPCI only. Notably, patients in the manual TA group were more likely to have TIMI flow 0 before pPCI (79.8% vs. 56.4%; pb0.001) compared with PCI-alone patients. Procedural success rates, defined as rates of post-procedural TIMI flow grade 3, was not statistically different between manual TA and PCI-alone treated patients (p=0.57). The baseline and procedural characteristics of the study population according to TIT group are summarized in Supplementary Table 1 .
Univariate analysis
Crude rates of in-hospital all-cause mortality [ (Table II) . There was a significantly increased unadjusted risk of myocardial reinfarction (1.0% vs. 0.4%; OR 2.60; 95% CI 1.14 to 5.96; p=0.02) in patients undergoing manual TA compared with patients in the PCI-alone group (Table II) .
In patients with short (b3 hours) and intermediate (3-6 hours) TIT, there were no significant differences between manual TA and PCI alone with respect to crude rates of in-hospital all-cause mortality (4.3% vs. 5.0%; p=0.56, and 2.5% vs. 3.0%; p=0.63, respectively) and MACE (5.6% vs. 5.5%; p=0.94, and 4.0 % vs. 4.2%; p= 0.91) (Table III) . There was no significant continuous association between TIT and in-hospital all-cause mortality (p=0.20) and MACE (p=0.30). In patients with prolonged TIT (N6 hours), crude rates of all-cause death (4.6% vs. 2.4%; OR 1.97, p=0.04) and MACE (5.7% vs. 2.4%; OR 2.17, p=0.01) were significantly higher with manual TA compared with PCI alone. However, interaction testing between manual TA versus PCI only and TIT groups did not demonstrate significant interaction with respect to all-cause mortality (joint p-value 0.09) and MACE (joint p-value for MACE p= 0.09).
Among patients in the TA group, there were no significant differences with respect to crude rates of all-cause mortality (4.3%, 2.5%, and 4.6% for TIT b3, 3 to 6, and N6 hours, respectively, p for trend=0.12) and MACE (5.6%, 4%, 5.7% for TIT b3, 3 to 6, and N6 hours, respectively, p for trend=0.32) according to TIT (Table  III) . Unadjusted in-hospital all-cause mortality rates were marginally lower in patients with intermediate TIT (3-6 hours) undergoing manual TA compared with patients with either shorter (2.5% vs. 4.3%, p=0.09) or longer (2.5% vs. 4.6%, p=0.07) times to treatment (Table III) . However, there was no significant association between in-hospital all-cause mortality or MACE and continuous TIT in both TA (p=0.99 and p=0.82, respectively) and PCI-alone (p=0.11 and p=0.32, respectively).
Multivariate analysis
Multivariable analysis was performed to account for confounding variables and potential bias between treatment groups. After adjustment for age, gender, diabetes mellitus, hypertension, TIT, chronic renal failure, cardiogenic shock, anterior STEMI, and multivessel disease, in-hospital all-cause mortality rates were not significantly different between manual TA and PCI-alone groups (OR 1.29; 95% CI 0.83-1.98; p=0.26) (Table II, Figure 2) , whereas there was a significantly increased adjusted risk of MACE (OR 1.52; 95% CI 1.05-2.19; p=0.03) among patients treated with manual TA compared with PCI alone (Table IV) , driven by an increased risk of myocardial reinfarction (OR 2.45; 95% CI 1.05-5.76; p= 0.04) (Table II) . There was no significant difference between manual TA and PCI alone with respect to risk-adjusted all-cause mortality according to TIT (Table  IV) . Compared with PCI-only treated patients, there was a significantly increased adjusted risk of MACE (OR 2.42; 95% CI 1.16-5.04; p=0.02) among patients with prolonged TIT (N6 hours) undergoing manual TA (Table IV) . However, no significant interaction between manual TA and TIT groups was found for in-hospital all-cause mortality (p=0.68) and MACE (p=0.57 Table 2 ).
Discussion
The major findings of the present study can be summarized as follows: (1) manual TA during pPCI did not reduce risk-adjusted in-hospital all-cause mortality rates compared with PCI alone irrespective of TIT; (2) manual TA during pPCI was associated with a significantly increased adjusted risk of MACE compared with PCI alone; and (3) manual TA in patients with prolonged TIT was associated with significantly increased risk-adjusted in-hospital MACE rates compared with PCI alone. To the best of our knowledge, this is the largest study evaluating the influence of TIT on the clinical benefit of manual TA during pPCI.
In our large registry of STEMI patients undergoing pPCI, routine manual TA did not reduce the risk of in-hospital all-cause death, MACE, and cardiogenic shock when compared with PCI alone, whereas there was a trend towards an increased risk of stroke. These findings are consistent with the results of two recent large-scale randomized clinical trials 6 -9 and subsequent meta-analyses 10, 20 demonstrating that routine manual TA during PCI for STEMI does not improve clinical outcomes at the expense of an increased risk of stroke, whereas there was a trend towards reduced cardiovascular death in the subgroup of patients with high thrombus burden. 10 However, current evidence is mainly limited to patients presenting within the first hours after symptom onset [6] [7] [8] [9] and the impact of TIT on manual TA efficacy in the contemporary pPCI era is currently uncertain, owing to the contradictory results of previous studies. 10, 14, 16, 17, 19, [23] [24] [25] [26] [27] Prolonged TIT in the setting of STEMI has been associated with suboptimal myocardial reperfusion, larger infarct size and increased 1-year mortality rates. [12] [13] [14] [15] 21 Patients presenting late after symptom onset display particularly high thrombus burden owing to long ischemic times, but data on manual TA efficacy in the subgroup of patients with STEMI presenting late after symptom onset are scarce and matter of debate. Prior small-sized randomized studies 16, 24 and post-hoc meta-regression analysis of early randomized trials 17 suggested that manual TA may indeed be more effective in the subgroup of late-presenting patients undergoing pPCI. In the VAcuuM asPIration thrombus REmoval (VAMPIRE) study, manual TA was shown to significantly improve myocardial reperfusion and reduce adverse ischemic events compared with PCI-alone when performed among patients presenting between 6 and 24 hours after symptom onset compared to patients treated with early (b6 hours) reperfusion. 24 However, in the largest cohort of late-presenting STEMI patients undergoing cardiac magnetic resonance imaging for the assessment of myocardial reperfusion, manual TA did not reduce the extent of microvascular obstruction and clinical outcomes compared with PCI alone as the result of only a moderate amount of salvageable myocardium at later stages. 26 Our results demonstrate no significant association with respect to risk-adjusted all-cause mortality between manual TA and PCI alone, whereas manual TA was associated with a significantly increased adjusted risk of MACE compared with pPCI alone, mainly driven by an increased risk of myocardial reinfarction. These findings suggest that manual TA may not be appropriate for patients with prolonged TIT and add new insights on the crucial issue of the appropriate selection of STEMI patient subsets that might derive benefit from the selective use of manual TA during pPCI.
The results of the present analysis are consistent with several previous large studies. [4] [5] [6] [7] [8] [9] [10] 19, 23 No influence of TIT on manual TA efficacy was observed in the single-center Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Myocardial Infarction Study (TAPAS) 4, 5 and the large multicenter Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia (TASTE) 6, 7 and Trial of Routine Aspiration Thrombectomy With PCI Versus PCI Alone (TOTAL) 8, 9 randomized trials. Individual patient-level meta-analysis of these trials did not demonstrate significant differences with respect to cardiovascular death at 30 days between manual TA and PCI-only in patients with TIT N6 hours and between 6 and 12 hours, whereas numerically higher cardiovascular mortality rates were found among patients with prolonged (N12 hours) times from symptom onset in the manual TA group compared with PCI-alone treated patients. 19 Furthermore, meta-regression analysis of a large meta-analysis did not identify any potential benefits of manual TA with respect to all-cause death based on TIT. 10 However, at variance from the results of our large contemporary STEMI cohort, the study did not demonstrate significant differences with respect to MACE based on TIT. 10 The mechanistic insights underlying the influence of TIT on clinical outcomes following manual TA cannot be directly derived from our study. However, intracoronary thrombus formation in STEMI patients is a dynamic process and thrombus composition may play an important role. Whereas thrombotic material is relatively soft at initial stages (low fibrin content, high platelet content), thrombus becomes more organized over time (high fibrin content, low platelet content). Thus, thrombus is possibly less suited for manual TA and more likely to disrupt resulting in significant iatrogenic distal embolization at later stages, 21 where additionally there is no, or only minimal, residual myocardium to be salvaged. 26 Finally, as observed in the current analysis, patients undergoing manual TA are substantially younger, with one-vessel disease and without prior myocardial infarction compared with patients treated with PCI-alone. This lower atherosclerotic burden might result in reduced tolerance to acute myocardial ischemia and increased susceptibility to worse clinical outcomes among patients undergoing manual TA.
Our data must be interpreted in view of several limitations. First, our study includes all limitations of a large nationwide registry, such as potential bias and unmeasured confounders associated with nonrandomized studies. Highest-risk patients may not have been considered for an invasive management and we cannot exclude the possibility of underreporting of clinical outcomes. In addition, the potential effect of confounding by indication on MACE rates cannot be formally excluded. The use of manual TA was left at the discretion of the operator and a potential selection bias with inclusion of lesions with higher thrombus burden in the TA group cannot be excluded. Despite the large size of our study population, our cohort may not have the power to detect differences in rates of in-hospital all-cause mortality related to the use of manual TA among subgroups of STEMI patients. All-cause mortality rates reported in our large contemporary cohort of STEMI patients treated with pPCI were low, suggesting a potential quantitative interaction, thus underestimating the treatment benefit in this 'low-risk' patient population.
Finally, thrombus grade and findings on the results of manual TA such as no retrieval of debris or failure of the catheter to cross the culprit lesion were not recorded.
Conclusion
In a large cohort of patients with STEMI undergoing pPCI, manual TA was not associated with lower risk-adjusted in-hospital all-cause mortality compared with PCI-alone regardless of TIT but was associated with significantly greater risk of MACE. In patients with prolonged TIT, manual TA was associated with higher risk-adjusted MACE rates compared with PCI-alone. These results warrant confirmation by further analyses from existing randomized clinical trials.
